Logo image of ALRPD.PA

RAPID NUTRITION PLC (ALRPD.PA) Stock Fundamental Analysis

EPA:ALRPD - Euronext Paris - Matif - GB00BM9PTW47 - Common Stock - Currency: EUR

0.0059  0 (-3.28%)

Fundamental Rating

2

Taking everything into account, ALRPD scores 2 out of 10 in our fundamental rating. ALRPD was compared to 58 industry peers in the Food Products industry. ALRPD has a great financial health rating, but its profitability evaluates not so good. ALRPD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALRPD has reported negative net income.
The reported net income has been mixed in the past 5 years: ALRPD reported negative net income in multiple years.
In the past 5 years ALRPD always reported negative operating cash flow.
ALRPD.PA Yearly Net Income VS EBIT VS OCF VS FCFALRPD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -252.95%, ALRPD is doing worse than 96.43% of the companies in the same industry.
ALRPD's Return On Equity of -268.63% is on the low side compared to the rest of the industry. ALRPD is outperformed by 92.86% of its industry peers.
Industry RankSector Rank
ROA -252.95%
ROE -268.63%
ROIC N/A
ROA(3y)-203.72%
ROA(5y)-165.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALRPD.PA Yearly ROA, ROE, ROICALRPD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

1.3 Margins

With a Gross Margin value of 8.56%, ALRPD is not doing good in the industry: 91.07% of the companies in the same industry are doing better.
ALRPD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALRPD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.3%
GM growth 5Y-25.51%
ALRPD.PA Yearly Profit, Operating, Gross MarginsALRPD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

7

2. Health

2.1 Basic Checks

ALRPD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALRPD has more shares outstanding
ALRPD has a better debt/assets ratio than last year.
ALRPD.PA Yearly Shares OutstandingALRPD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
ALRPD.PA Yearly Total Debt VS Total AssetsALRPD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -35.65, we must say that ALRPD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -35.65, ALRPD is doing worse than 94.64% of the companies in the same industry.
There is no outstanding debt for ALRPD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -35.65
ROIC/WACCN/A
WACCN/A
ALRPD.PA Yearly LT Debt VS Equity VS FCFALRPD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

A Current Ratio of 17.13 indicates that ALRPD has no problem at all paying its short term obligations.
ALRPD has a better Current ratio (17.13) than 100.00% of its industry peers.
ALRPD has a Quick Ratio of 14.78. This indicates that ALRPD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 14.78, ALRPD belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 17.13
Quick Ratio 14.78
ALRPD.PA Yearly Current Assets VS Current LiabilitesALRPD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ALRPD have decreased strongly by -62.50% in the last year.
The Revenue for ALRPD has decreased by -20.51% in the past year. This is quite bad
Measured over the past years, ALRPD shows a very negative growth in Revenue. The Revenue has been decreasing by -16.78% on average per year.
EPS 1Y (TTM)-62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
Revenue 1Y (TTM)-20.51%
Revenue growth 3Y-23.38%
Revenue growth 5Y-16.78%
Sales Q2Q%-57.58%

3.2 Future

ALRPD is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -18.92% yearly.
The Revenue is expected to decrease by -8.40% on average over the next years.
EPS Next Y-100%
EPS Next 2Y-41.42%
EPS Next 3Y-25.99%
EPS Next 5Y-18.92%
Revenue Next Year-49.49%
Revenue Next 2Y-25.39%
Revenue Next 3Y-14.52%
Revenue Next 5Y-8.4%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALRPD.PA Yearly Revenue VS EstimatesALRPD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M
ALRPD.PA Yearly EPS VS EstimatesALRPD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 5 10 15 20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ALRPD.PA Price Earnings VS Forward Price EarningsALRPD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALRPD.PA Per share dataALRPD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 0.01

4.3 Compensation for Growth

A cheap valuation may be justified as ALRPD's earnings are expected to decrease with -25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.42%
EPS Next 3Y-25.99%

More info and screens

0

5. Dividend

5.1 Amount

ALRPD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RAPID NUTRITION PLC

EPA:ALRPD (4/25/2025, 7:00:00 PM)

0.0059

0 (-3.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)05-20 2025-05-20/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap697.50K
Analysts84.44
Price Target0.51 (8544.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.21%
Revenue NY rev (3m)1.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.97
P/FCF N/A
P/OCF N/A
P/B 1.08
P/tB 1.08
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.01
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -252.95%
ROE -268.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.56%
FCFM N/A
ROA(3y)-203.72%
ROA(5y)-165.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.3%
GM growth 5Y-25.51%
F-ScoreN/A
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.13
Quick Ratio 14.78
Altman-Z -35.65
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
EPS Next Y-100%
EPS Next 2Y-41.42%
EPS Next 3Y-25.99%
EPS Next 5Y-18.92%
Revenue 1Y (TTM)-20.51%
Revenue growth 3Y-23.38%
Revenue growth 5Y-16.78%
Sales Q2Q%-57.58%
Revenue Next Year-49.49%
Revenue Next 2Y-25.39%
Revenue Next 3Y-14.52%
Revenue Next 5Y-8.4%
EBIT growth 1Y32.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-122.88%
EBIT Next 3Y-58.71%
EBIT Next 5Y-27.07%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A